Cozzens Todd C 4

4 · Natera, Inc. · Filed Mar 11, 2021

Form 4

Period: 2021-03-09

Director

Transactions

Exercise/Conversion
Common Stock
2021-03-09$1.39/sh+29,475$40,838→ 36,753 total
Sale
Common Stock
2021-03-09$100.35/sh−29,475$2,957,875→ 7,278 total
Exercise/Conversion
Common Stock
2021-03-11$1.39/sh+20,000$27,710→ 27,278 total
Sale
Common Stock
2021-03-11$103.38/sh−9,283$959,658→ 17,995 total
Sale
Common Stock
2021-03-11$103.97/sh−10,717$1,114,214→ 7,278 total
Exercise/Conversion
Stock Option (right to buy)
2021-03-04−20,000→ 31,383 total
Exercise: $1.39Exp: 2023-04-17→ Common Stock (20,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2021-03-09−29,475→ 51,383 total
Exercise: $1.39Exp: 2023-04-17→ Common Stock (29,475 underlying)

Footnotes (4)

[F1]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.98 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.70 to $103.69 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.71 to $104.17 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]The option vests in 48 equal monthly installments beginning on April 21, 2013.

Documents

1 file